Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00280267 · ClinicalTrials.gov registry record · Phase 2
Testosterone Therapy After Hip Fracture in Elderly Women
A Phase 2 study of Muscle Weakness and Hip Fracture, sponsored by Washington University School of Medicine.
- Completed
- Registry status
- Phase 2
- Development phase
- 15
- Enrollment target
- 1
- Study location
NCT00280267: Completed Phase 2 study of Muscle Weakness and Hip Fracture, sponsored by Washington University School of Medicine.
NCT00280267 is a Phase 2 study of Muscle Weakness and Hip Fracture that has completed, run by Washington University School of Medicine. The registered enrollment target is 15 participants, below the 74-participant average among 25 other Muscle Weakness trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00280267, a Phase 2 study of Muscle Weakness and Hip Fracture, has completed, sponsored by Washington University School of Medicine.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to determine the feasibility of testosterone replacement therapy in frail elderly female hip fracture patients who have testosterone deficiency, and to obtain preliminary information about the effects of testosterone therapy on muscle strength and size, bone density, mobility, daily functioning, and quality of life.
Conditions Studied
Interventions
- DRUG Testosterone gel
Study Locations (1)
Missouri
- Washington University School of Medicine, Division of Geriatrics and Nutritional Science - St Louis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2004-08 |
| Est. Completion | 2006-12 |
| Phase | Phase 2 |
What the finished NCT00280267 record still lists
NCT00280267 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 74-participant average among 25 other Muscle Weakness trials with a reported enrollment target (80% lower).
The record links to 3 conditions, with Muscle Weakness appearing as the primary indexed condition, and to 1 intervention - of which Testosterone gel is the first listed.
NCT00280267 reports a single indexed study location in Missouri.
Frequently Asked Questions
What is clinical trial NCT00280267 about?
NCT00280267 is a clinical study titled "Testosterone Therapy After Hip Fracture in Elderly Women". The purpose of this study is to determine the feasibility of testosterone replacement therapy in frail elderly female hip fracture patients who have testosterone deficiency, and to obtain preliminary information about the effects of testosterone therapy on muscle strength and size, bone density, mob...
What is the current status of trial NCT00280267?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 15 participants. The study started on 2004-08. Estimated completion is 2006-12.
What conditions does trial NCT00280267 study?
This clinical trial studies the following conditions: Muscle Weakness, Hip Fracture, Testosterone Deficiency.
What interventions are being tested in trial NCT00280267?
The interventions under investigation include: Testosterone gel (DRUG).
Who is sponsoring clinical trial NCT00280267?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00280267 being conducted?
This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Muscle Weakness
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00280267's enrollment target sits among peer trials
15 25th of 25 higher than 1 of 25 other Muscle Weakness trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Muscle Weakness trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
HORMA: Hormonal Regulators of Muscle and Metabolism in Aging
COMPLETED · Phase 2
-
Effect of Weight Loss on Intermuscular Adipose Tissue (IMAT) Signaling
RECRUITING · NA
-
Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adults
RECRUITING
-
FIT Exercise in 30d of ULLS-induced Muscle Disuse
RECRUITING · NA
-
Muscle Recovery After Critical Illness
RECRUITING
-
THRIVE Well Cancer FDTN/Exercise_Creatine Supplementation
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01889381 · 15 participants · Phase 2
Human Craniomaxillofacial Allotransplantation
- NCT02530073 · 15 participants · NA
Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH
- NCT02535936 · 15 participants · NA
Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy
- NCT02918474 · 15 participants · NA
Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia